Gabapentin

Printer-friendly version

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

Revision history
- Jan. 2022, Nov. 2019; Nov. 2017; Sept. 2015; Dec. 2013; Jan. 2012; Dec. 2011; April 2010; Aug. 2006.
Initially developed
- June 2006